As the year unfolds the biotech industry will look closely at these ten first-in-class drugs on track to reach FDA approval ...

The month of December 2024 saw a variety of biotech deals take place to advance therapies across different stages in ...

The companies Nuvig Therapeutics, Ottimo Pharma, and Angitia Biopharmaceuticals bagged the biggest private biotech ...

Some other medicines that are slated to become blockbusters in the near future include GSK’s vaccine candidate GSK-3536819 ...

Explore advances in von Willebrand disease treatment, including Star Therapeutics' VGA039, and other key players in the space ...

Starting a biotech is a daunting task with a lot of parameters. And if you’re only starting, the chances are you don’t have all the resources and knowledge it takes to be successful or as efficient as ...

Various PD-1 and PD-L1 checkpoint inhibitors have been approved by U.S. regulators including blockbuster drugs Keytruda, Imfinzi, and Opdivo to treat different types of cancer. But that hasn’t stopped ...